SAP: Prelim. FY15 results at the high-end of company guidance, FY16 guidance almost in line
NEUTRAL, Fair Value EUR75 (+6%)
Innate Pharma: Out-licensing deal with Sanofi and in-licensing with OREGA Biotech
BUY, Fair Value EUR19 (+48%)
Carlsberg: Things are going to get worse before they get better. Downgrade to sell.
SELL vs. NEUTRAL, Fair Value DKK485 vs. DKK519 (-18%)
Casino Guichard: FIRST TAKE COMMENT: a guidance engraved in stone
BUY, Fair Value EUR69 (+57%)
Celyad: CHART-2 cleared by the FDA
BUY, Fair Value EUR81 vs. EUR71 (+75%)
Be ready for the upcoming takeover bid on Gameloft (hostile or friendly)!
BUY, Fair Value EUR6.7 (+12%)
Casino Guichard: Slander as much as you like! There will always be something left!
BUY, Fair Value EUR69 (+59%)
ELIOR: FY results First take: Slightly better
BUY, Fair Value EUR20 (+15%)